Gevo, Inc.
General ticker "GEVO" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $443.8M (TTM average)
Gevo, Inc. does not follow the US Stock Market performance with the rate: -27.5%.
Estimated limits based on current volatility of 3.0%: low 1.63$, high 1.73$
Factors to consider:
- Total employees count: 151 (+23.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Inability to achieve profitability, Inability to raise capital, Product development failure, Commercial scale operations, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.24$, 2.57$]
- 2026-12-31 to 2027-12-31 estimated range: [0.97$, 2.11$]
Financial Metrics affecting the GEVO estimates:
- Positive: with PPE of -15.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.77 <= 0.28
- Positive: -9.15 < Industry operating profit margin (median), % of 1.52
- Positive: Inventory ratio change, % of -18.60 <= -0.75
- Positive: 0.01 < Industry earnings per price (median), % of 2.85
- Positive: Shareholder equity ratio, % of 64.87 > 63.63
- Positive: 0 < Industry operating cash flow per share per price (median), % of 5.08
Short-term GEVO quotes
Long-term GEVO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $17.20MM | $16.91MM | $163.67MM |
| Operating Expenses | $99.03MM | $107.74MM | $183.88MM |
| Operating Income | $-81.83MM | $-90.82MM | $-20.21MM |
| Non-Operating Income | $15.62MM | $12.18MM | $-12.42MM |
| Interest Expense | $2.16MM | $3.88MM | $17.56MM |
| R&D Expense | $21.37MM | $23.74MM | $16.20MM |
| Income(Loss) | $-66.22MM | $-78.64MM | $-32.63MM |
| Net Income(Loss)* | $-66.22MM | $-78.64MM | $-33.84MM |
| Stockholders Equity | $557.39MM | $489.49MM | $466.34MM |
| Inventory | $3.81MM | $4.50MM | $4.06MM |
| Assets | $650.32MM | $583.94MM | $718.93MM |
| Operating Cash Flow | $-53.72MM | $-57.38MM | $-13.40MM |
| Capital expenditure | $54.45MM | $51.09MM | $30.11MM |
| Investing Cash Flow | $114.13MM | $-51.82MM | $-226.57MM |
| Financing Cash Flow | $-0.19MM | $-7.36MM | $97.88MM |
| Earnings Per Share** | $-0.28 | $-0.34 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.